US Cannabis Market By Source (Hemp (Hemp Oil, and Industrial Hemp), Marijuana (Flower, and Oil & Tinctures)), By Derivatives (CBD, THC, and Others), By Cultivation (Indoor Cultivation, Greenhouse Cultivation, and Outdoor Cultivation), By End-use (Industrial Use, Medical Use (Chronic Pain, Depression & Anxiety, Arthritis, and Others), and Recreational Use), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Competitive Landscape
  • 1.6. Taxonomy
• 2. Market Overview
  • 2.1. Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key US Cannabis Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of US Cannabis Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Impact of Macro-economic Factors/Geopolitical Factors
• 3. US Cannabis Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. US Cannabis Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
  • 3.3. US Cannabis Market Attractiveness Analysis, By Source
    • 3.3.1. Marijuana
      • • 3.3.1.1. Insights
        • 3.3.1.2. Key Takeaways
          • 3.3.1.2.1. Flower
          • 3.3.1.2.2. Oil & Tinctures
    • 3.3.2. Hemp
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
        • 3.3.2.2.1. Hemp Oil
        • 3.3.2.2.2. Industrial Hemp
  • 3.4. US Cannabis Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Derivatives, 2020-2034
  • 3.5. US Cannabis Market Attractiveness Analysis, By Derivatives
    • 3.5.1. CBD
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. THC
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Others
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
  • 3.6. US Cannabis Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Cultivation, 2020-2034
  • 3.7. US Cannabis Market Attractiveness Analysis, By Cultivation
    • 3.7.1. Indoor Cultivation
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Greenhouse Cultivation
      • • 3.7.2.1. Insights
        • 3.7.2.2. Key Takeaways
    • 3.7.3. Outdoor Cultivation
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
  • 3.8. US Cannabis Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2020-2034
  • 3.9. US Cannabis Market Attractiveness Analysis, By End-use
    • 3.9.1. Recreational Use
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Medical Use
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
      • 3.9.2.2.1. Chronic Pain
      • 3.9.2.2.2. Depression & Anxiety
      • 3.9.2.2.3. Arthritis
      • 3.9.2.2.4. Others
    • 3.9.3. Industrial Use
      • 3.9.3.1. Insights
      • 3.9.3.2. Key Takeaways
• 4. Competitive Landscape & Company Profiles
  • 4.1. Market Competition Scenario Analysis, By Company
    • 4.1.1. Key Takeaways
  • 4.2. Overview of Major Market Players
  • 4.3. Competitor Landscape
  • 4.4. Strategic Mapping
  • 4.5. Company Life Cycle Analysis
  • 4.6. Company Market Share Analysis
  • 4.7. Company Profiles
    • 4.7.1. Tilray Brands
      • 4.7.1.1. Company Details
      • 4.7.1.2. Business Overview
      • 4.7.1.3. Product Portfolio
      • 4.7.1.4. Financial Insights
      • 4.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.1.6. SWOT Analysis
      • 4.7.1.7. Geographic Footprint
    • 4.7.2. The Cronos Group
      • 4.7.2.1. Company Details
      • 4.7.2.2. Business Overview
      • 4.7.2.3. Product Portfolio
      • 4.7.2.4. Financial Insights
      • 4.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.2.6. SWOT Analysis
      • 4.7.2.7. Geographic Footprint
    • 4.7.3. Organigram Holding, Inc
      • 4.7.3.1. Company Details
      • 4.7.3.2. Business Overview
      • 4.7.3.3. Product Portfolio
      • 4.7.3.4. Financial Insights
      • 4.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.3.6. SWOT Analysis
      • 4.7.3.7. Geographic Footprint
    • 4.7.4. Irwin Naturals
      • 4.7.4.1. Company Details
      • 4.7.4.2. Business Overview
      • 4.7.4.3. Product Portfolio
      • 4.7.4.4. Financial Insights
      • 4.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.4.6. SWOT Analysis
      • 4.7.4.7. Geographic Footprint
    • 4.7.5. CV Sciences, Inc
      • 4.7.5.1. Company Details
      • 4.7.5.2. Business Overview
      • 4.7.5.3. Product Portfolio
      • 4.7.5.4. Financial Insights
      • 4.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.5.6. SWOT Analysis
      • 4.7.5.7. Geographic Footprint
    • 4.7.6. Charlotte’s Web
      • 4.7.6.1. Company Details
      • 4.7.6.2. Business Overview
      • 4.7.6.3. Product Portfolio
      • 4.7.6.4. Financial Insights
      • 4.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.6.6. SWOT Analysis
      • 4.7.6.7. Geographic Footprint
    • 4.7.7. Canopy Growth Corporation
      • 4.7.7.1. Company Details
      • 4.7.7.2. Business Overview
      • 4.7.7.3. Product Portfolio
      • 4.7.7.4. Financial Insights
      • 4.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.7.6. SWOT Analysis
      • 4.7.7.7. Geographic Footprint
    • 4.7.8. Aurora Cannabis
      • 4.7.8.1. Company Details
      • 4.7.8.2. Business Overview
      • 4.7.8.3. Product Portfolio
      • 4.7.8.4. Financial Insights
      • 4.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 4.7.8.6. SWOT Analysis
      • 4.7.8.7. Geographic Footprint
• 5. Methodology and Data Source
  • 5.1. Methodology/Research Approach
  • 5.2. Market Size Estimation
  • 5.3. Market Breakdown and Data Triangulation
  • 5.4. Data Source
  • 5.5. Secondary Sources
  • 5.6. Primary Sources
  • 5.7. Appendix
  • 5.8. Disclaimer

List of Tables

• Table 1. US Cannabis Market Value (US$ Mn), By Source, 2020-2034
• Table 2. US Cannabis Market Value (US$ Mn), By Hemp, 2020-2034
• Table 3. US Cannabis Market Value (US$ Mn), By Marijuana, 2020-2034
• Table 4. US Cannabis Market Value (US$ Mn), By Derivatives, 2020-2034
• Table 5. US Cannabis Market Value (US$ Mn), By Cultivation, 2020-2034
• Table 6. US Cannabis Market Value (US$ Mn), By End-use, 2020-2034
• Table 7. US Cannabis Market Value (US$ Mn), By Medical Use, 2020-2034
• List of Figures
• Figure 1. US Cannabis Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. US Cannabis Market Analysis, By Source, 2020, 2024 and 2034
• Figure 5. US Cannabis Market Attractiveness Analysis, By Source
• Figure 6. US Cannabis Market Analysis, By Derivatives, 2020, 2024 and 2034
• Figure 7. US Cannabis Market Attractiveness Analysis, By Derivatives
• Figure 8. US Cannabis Market Analysis, By Cultivation, 2020, 2024 and 2034
• Figure 9. US Cannabis Market Attractiveness Analysis, By Cultivation
• Figure 10. US Cannabis Market Analysis, By End-use, 2020, 2024 and 2034
• Figure 11. US Cannabis Market Attractiveness Analysis, By End-use